Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R J Lansdown

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2003
Correspondence re: K. Heer et al., serum vascular endothelial growth factor in breast cancer: its relation with cancer type and estrogen receptor status. Clin. Cancer Res., 7: 3491-3494, 2001Claire E Murphy, Mark R J Lansdown, Valerie Speirs, et al.
Breast Cancer Research : BCR|March 13, 2003
Breast cancer cell lines: friend or foe?Sarah E Burdall, Andrew M Hanby, Mark R J Lansdown, et al.
Annals of the Royal College of Surgeons of England|October 25, 2006
Appendicectomy: who performs it, when and how?Mark R J Lansdown, Anthony J G Gray, Tom Treasure, et al.
The Lancet. Oncology|March 9, 2004
Oestrogen receptor beta: what it means for patients with breast cancerValerie Speirs, Pauline J Carder, Sally Lane, et al.
The Journal of Pathology|October 1, 2003
Reduced expression of oestrogen receptor beta in invasive breast cancer and its re-expression using DNA methyl transferase inhibitors in a cell line modelGeorge P Skliris, Kailas Munot, Sandra M Bell, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2003
Correspondence re: K. Heer et al., serum vascular endothelial growth factor in breast cancer: its relation with cancer type and estrogen receptor status. Clin. Cancer Res., 7: 3491-3494, 2001Claire E Murphy, Mark R J Lansdown, Valerie Speirs, et al.
Breast Cancer Research : BCR|March 13, 2003
Breast cancer cell lines: friend or foe?Sarah E Burdall, Andrew M Hanby, Mark R J Lansdown, et al.
Annals of the Royal College of Surgeons of England|October 25, 2006
Appendicectomy: who performs it, when and how?Mark R J Lansdown, Anthony J G Gray, Tom Treasure, et al.
The Lancet. Oncology|March 9, 2004
Oestrogen receptor beta: what it means for patients with breast cancerValerie Speirs, Pauline J Carder, Sally Lane, et al.
The Journal of Pathology|October 1, 2003
Reduced expression of oestrogen receptor beta in invasive breast cancer and its re-expression using DNA methyl transferase inhibitors in a cell line modelGeorge P Skliris, Kailas Munot, Sandra M Bell, et al.
Pageof 1